Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...

Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical API Manufacturing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pharmaceutical API manufacturing market has ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Swiss firm CordenPharma is acquiring Aiken County peptide manufacturer AmbioPharm to expand its global drug production.

Highlighting advanced manufacturing capabilities, stringent quality standards, and reliable supply for pharmaceutical ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...